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ORIGINAL RESEARCH
Objective: To investigate the risk profile of patients with thrombosis and emboli, and
prognostic factors for death or amputation in patients presenting with acute limb ischemia in
a tertiary care regional hospital in Brazil.
Methods: A prospectively planned cohort study was carried out in which 83 patients with
acute limb ischemia, secondary to thrombosis, or embolism, classified in stages II and III of
severity were evaluated. Univariate analysis and logistic regression models were used to explore
the relationship between anthropometric and demographic characteristics, comorbidities,
cardiovascular risk factors, duration of occlusion, and type of surgery with the incidence of
amputation or death, which were evaluated in 30 days and 1 year thereafter.
Results: Male gender, smoking, and comorbidities were more frequent among patients with
thrombosis, and atrial fibrillation was more common among patients with embolism. Occlusion
longer than 24 hours (odds ratio [OR] 2.6, 95% confidence interval [CI] 1.1–7.6) and a trend
for diabetes (RR 2.6, 95% CI 0.9–7.5) were the characteristics associated with death or
amputation in the multivariate analysis, which occurred in 15 (18.1%) and 24 (28.9%) of the
participants, respectively. Reperfusion injury was a risk factor for death but not for amputation
(OR 16.9, 95% CI 1.1–232.9) after adjustment for age, duration of occlusion, and diabetes.
Conclusions: Traditional and avoidable risk factors explain the occurrence of thrombosis
and embolism in our region. Access to medical care is the most important and modifiable
prognostic factor for death or amputation.
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Introduction
Cardiovascular disease is the leading cause of death in Brazil (Mansur et al 2001).
Acute limb ischemia is responsible for a high proportion of morbidity and mortality
attributable to cardiovascular disease. It is caused by thrombosis or embolism from
the heart or major arterial branches (Haimovici 1982; Perry 1995; Murabito et al
1997). Surgical revascularization or endovascular therapy is a major determinant of
not only limb but also life survival in such a population of patients (Hertzer 1991).
The results of the surgical revascularization by thromboembolectomy or bypass may
be influenced by several prognostic factors: eg, antecedent cardiovascular risk factors,
duration and presentation of the acute episode, surgical technique, and location of
occlusion, to mention a few (Perry 1995; Rutherford et al 1997; TASC 2000). The
identification of different prognostic factors may reflect the experience of different
centers, but may be also biased by confounding factors. Prognosis of patients with
embolism was previously described (Aune and Trippestad 1998), but we are not
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to thrombosis or embolism treated surgically in our country.
In this study, we compared the risk profile of patients with
thrombosis and embolism, and investigated prognostic
factors for death or amputation in patients with acute limb
ischemia classified in stages II and III of severity (Rutherford
et al 1997).
Methods
A prospectively planned cohort study was carried out in a
tertiary care regional hospital through a prospective registry
format. Patients were referred from provincial hospitals or
were seeking assistance directly in our hospital. The
comprising cohort of patients was from a region with
approximately one million inhabitants. All patients with
acute limb ischemia, secondary to thrombosis, embolism,
or trauma, were screened. Acute limb ischemia was
characterized as a quick or sudden decrease in limb
perfusion, producing new or worsening symptoms, and signs
of threatening limb viability. Patients with embolism or
thrombosis in categories II and III of severity, and submitted
to surgical revascularization or primary amputation, were
enrolled in the study. The categories of acute limb ischemia
were classified according to the protocol of Rutherford et
al (1997).
The protocol included assessment of anthropometric and
demographic data, comorbidities and risk factors, duration
of occlusion, and type of surgery. Hypertension, hyper-
cholesterolemia, and diabetes were characterized by history
or use of blood pressure-lowering drugs, hypolipemiant, or
antidiabetic drugs. Past (time of quitting not specified) and
current smokers were classified as smokers. Coronary heart
disease was diagnosed in the presence of a history of a
previous myocardial infarction, angina or a “Q” wave in
the electrocardiogram. Atrial fibrillation was diagnosed by
an electrocardiogram taken during the acute vascular
episode. The diagnosis of stroke was based on history or
evidence of motor deficit. Previous peripheral artery disease
was characterized by history of intermittent claudication.
Renal insufficiency was defined by creatinine over 3.0 mg
per deciliter or hemodialysis. Duration of occlusion was
estimated by the time between the onset symptoms of acute
limb ischemia (first symptoms) and the arrival in the
emergency room of our hospital. The American Society of
Anesthesiologists (ASA) risk category was used by the
anesthesiologist for the purpose of classification.
Six vascular surgeons, all with 3–5 years of training in
medical residency, and with at least 5 years of experience,
performed all surgeries.
The primary outcome was the occurrence of death or
amputation in 30 days and 1 year. These events were
analyzed separately as secondary outcomes. The occurrence
of death or amputation by several prognostic characteristics
was tested by the Chi square test. Student’s t-test was
employed to test for differences in continuous variables
between patients with thrombosis and embolism. Logistic
regression models were used to explore the relationship
between prognostic factors for amputation or death in 30
days. A Cox proportional hazard model was used to explore
these associations during the follow-up of 1-year, including
time-to-event as covariate.
The study was approved by the Ethical Committee of
our Institution. We ensured the anonymous identification
of the participants.
Results
In total, 83 sequential patients with acute limb ischemia
classified in the Rutherford categories II and III (16 in
category III) of severity, were enrolled between 1997 and
2000. The cohort was followed for 1 month and 3 were lost
after this period in the follow-up to one year. The main cause
of limb ischemia in this cohort was thrombosis (56.6%) with
the remaining cause being due to emboli (43.4%). The
demographics of patients studied are presented in Table 1.
It is evident that patients with thrombosis were more
frequently male and smokers. Comorbidities were also more
frequent among patients with thrombosis, with the exception
of atrial fibrillation, which was more common among
patients with embolism. Only 1 patient with embolism
Table 1 Demographics of population of patients with limb
ischemia that were studied (mean ± SD or n (%) within stratum)
Embolism Thrombosis
Characteristics (n = 36) (n = 47) p
Age (y) 67 ± 12 69 ± 10 NS
Male gender 12 (33.3) 36 (76.6) < 0.001
Previous vascular procedure 9 (25) 13 (27.7) NS
Duration of occlusion (h)  38 ± 79 41 ± 46 NS
Smoking 10 (27.8) 40 (85.1) < 0.001
Diabetes mellitus 7 (19.4) 20 (42.6) 0.034
Hypertension 15 (41.7) 17 (36.2) NS
Coronary artery disease 14 (38.9) 22 (46.8) NS
Cerebral vascular disease 0 7 (14.9) 0.017
Peripheral vascular disease 6 (16.7) 35 (74.5) < 0.001
Hyperlipidemia 7 (19.4) 1 (2.1) 0.019
Atrial fibrillation 20 (55.6) 11 (23.4) 0.003
Renal insufficiency 1 (2.8) 1 (2.1) NS
ASA 2.89 ± 0.46 2.83 ± 0.67 NS
Abbreviations: ASA, American Society of Anesthesiologists classification;
h, hours; y, years.Vascular Health and Risk Management 2005:1(4) 347
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and 2 with thrombosis were submitted to duplex scanning.
Angiography was done in 5 (13.9%) of the patients with
embolism and in 23 (48.9%) of the patients with thrombosis
(p < 0.001). Fasciotomy was done in 6 (16.7%) of the
patients with embolism and in 1 (2.1%) of the patients with
thrombosis (p = 0.039). The level of occlusion is presented
in Table 2 and the surgical procedures employed in the
management of these cases are presented in Table 3.
Occlusion at the level of superficial femoral artery accounted
for almost 50% of the cases of embolism and thrombosis.
In patients with embolism, the common femoral artery was
the second site of occlusion, while in patients with
thrombosis the external iliac artery was the second site of
occlusion. Almost all patients with embolism were treated
by thromboembolectomy, while the cases of thrombosis
were managed with bypass using venous and artificial grafts
and endarterectomy. Endovascular therapy and thrombolysis
were not in use at the time of data collection. Only patients
with thrombosis were submitted to primary amputation
(19.1%).
There were 15 (18.1%) deaths and 24 (28.9%)
amputations in the cohort of patients investigated. The
incidence of amputation or death according to the presence
of prognostic factors is presented in Table 4. Duration of
occlusion was one characteristic associated with a poor
prognosis while the presence of diabetes showed a trend
for poor prognosis. These associations persisted in a logistic
regression model that included themselves with age, gender,
hypertension, and cause of occlusion as explanatory
variables (Table 5). The same trends persisted during the
follow-up of one year, adjusting for the same set of
confounding variables. The hazard ratio for death or
amputation for duration of occlusion longer than 24 hours
was 1.7 (95% confidence interval [CI] 0.9–3.3). For diabetes
the hazard ratio was 1.6 (95% CI 0.8–2.9). Three cases were
censored at 1-month of follow-up.
In the logistic regression models that included death and
amputation separately as dependent variables, the odds ratios
(OR) were among the 95% confidence estimates of the
composite endpoint, and presented a similar trend for risk
Table 2 Level of occlusion in participants classified by the
cause of limb ischemia (n and %)
Embolism Thrombosis
Site (n = 36) (n = 47)
Infrarenal aorta 2 (5.6) 6 (12.8)
Common iliac 3 (8.3) 3 (6.4)
External iliac 4 (11.1) 8 (17.0)
Common femoral 6 ( 16.7) 1 (2.1)
Superficial femoral 14 (38.8) 19 (40.4)
Popliteal above-knee 5 (13.9) 6 (12.8)
Popliteal below-knee 0 4 (8.5)
Posterior tibial 2 (5.6) 0
Table 3 Type of surgical procedures to deal with limb
ischemia (n and %)
Embolism Thrombosis
Procedure (n = 36) (n = 47)
Thromboembolectomy 35 (97.2) 1 (2.1)
Bypass in situ GSV 10 (21.3)
Bypass reversed GSV 6 (12.8)
Bypass PTFE or Dacron 1 (2.8) 13 (27.7)
Primary amputation 9 (19.1)
Endarterectomy 7 (14.9)
Composite bypass 1 (2.1)
Abbreviations: GSV, greater saphenous vein; PTFE, polytetrafluoroethylene.
Table 4 Incidence of amputation or death by baseline
characteristics, duration of surgery, or cause of occlusion (n
and %)
Condition Amputation
Characteristics (n) or death p
Gender Female (35) 20 (57.1) 0.376
Male (48) 22 (45.8)
Age (y) < 65 (33) 15 (45.5) 0.505
> 65 (50) 27 (54.0)
Cause of occlusion Thrombosis (47) 24 (51.1) 1.0
Embolism (36) 18 (50.5)
Atrial fibrillation Yes (31) 16 (51.6) 1.0
No (52) 26 (50.0)
Cerebral vascular disease Yes (7) 4 (57.1) 1.0
No (76) 38 (50.0)
Coronary artery disease Yes (36) 21 (58.3) 0.270
No (47) 21 (44.7)
Diabetes mellitus Yes (27) 18 (66.7) 0.061
No (56) 24 (42.9)
Smoking Yes (50) 23 (46.0) 0.372
No (33) 19 (57.6)
Duration of occlusion (h) > 24 (42) 26 (63.4) 0.028
< 24 (41) 16 (38.1)
Hypertension Yes (32) 17 (53.1) 0.822
No (51) 25 (49.0)
Hyperlipidemia Yes (8) 3 (37.5) 0.717
No (75) 39 (52.0)
Peripheral vascular disease Yes (41) 21 (51.2) 1.0
No (42) 21 (50.0)
Angiography Yes (28) 11 (39.3) 0.168
No (55) 31 (56.4)
Level of occlusion Proximal (33) 16 (48.5) 0.824
Distal (50) 26 (52.0)
Abbreviations: h, hours; y, years.Vascular Health and Risk Management 2005:1(4) 348
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or protection. Hypertension showed a trend for protection
against amputation (OR 0.3, CI 0.1–1.1 p = 0.06) but was
associated with the risk of death (OR 3.7, CI 1.2–11.5,
p = 0.03).
The level of occlusion, stratified in proximal (aorta,
common iliac, external iliac, and common femoral artery)
and distal (superficial femoral, popliteal, anterior and
posterior tibial, and peroneal artery), was not associated with
the incidence of death, amputation, or both.
The incidence of reperfusion injury (limb swelling with
impaired muscle function with or without systemic
manifestations) due to ischemia was 6.0%, being restricted
to patients with embolism (13.9%). It was a risk factor for
death, but not for amputation in these patients (OR 16.9,
95% CI 1.1–232.9, p = 0.04) after adjustment for age,
duration of occlusion, and diabetes.
Discussion
Thrombosis was more frequent than embolism as a cause
of nontraumatic limb ischemia in our hospital. A higher
proportion of embolism (Aune and Trippestad 1998),
thrombosis (Ouriel and Veith 1998), and a similar frequency
of both conditions (Gutowski et al 1999) have been
described. Patients with thrombosis were more frequently
male and had higher prevalence of cardiovascular risk factors
and comorbidities, such as a previous diagnosis of peripheral
vascular disease and cerebrovascular disease. As expected,
patients with embolism more often had atrial fibrillation
(Brewster 1995).
The incidence of death or amputation was almost 50%
as described in other centers (Balas et al 1985; Littoy and
Baker 1986; Varty et al 1992; Braithwaite et al 1998). The
independent risk factor for an unfavorable outcome was
prolonged time between the beginning of symptoms and
the surgery. Diabetes also showed a trend for such risk (ie,
unfavorable outcome). These prognostic factors have been
previously described (Balas et al 1985; VSSGBI 1995;
TASC 2000). In the Basle study, it was reported that major
amputations were 11 times more frequent in diabetic patients
with peripheral arterial disease (PAD) than in nondiabetic
PAD patients (Da Silva et al 1979). Duration of occlusion
was the most important modifiable cause of amputation or
death in our cohort. We did not analyze specific causes for
the long interval between the beginning of symptoms and
the arrival at the emergency department. We speculate that
the low level of education of most patients, their fear of
doctors, and misdiagnosis may be underlying causes for such
catastrophic behavior.
Hypertension showed a trend for protection against
amputation but was significantly associated with a higher
risk of death. Although Jelnes et al (1986) noted that the
risk of deterioration was related to blood pressure, the study
by Dormandy and Murray (1991) did not find a significant
link between hypertension and prognosis after adjustment
for other risk factors. Our findings may be ascribed to
chance, but the possibility that higher blood pressure during
such events protects against the failure of grafts needs to be
further investigated in a systematic manner.
Cigarette smoking is a major risk for developing
peripheral arterial disease (Kannel and Shurtleff 1973; Da
Silva et al 1979), but we could not find any association
between smoking that influenced the prognosis of acute limb
ischemia. This risk factor deserves further investigation since
our negative findings could be attributed to sample size and
a lower statistical power of our study.
The incidence of reperfusion injury was restricted to
patients with embolism and was a risk factor for death. This
has been well recognized as a serious complication of
revascularization (TASC 2000).
In conclusion, acute limb ischemia caused by thrombosis
or embolia was identified as a serious medical event in our
hospital, being associated with high rates of mortality or
amputation. In general, atherosclerotic vascular disease was
a risk factor for thrombosis, while atrial fibrillation was a
strong risk factor for embolism. It seems that the time
interval for medical care and attention is one of the most
important and modifiable prognostic factors for either death
or amputation.
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